23-Valent Pneumococcal Polysaccharide Vaccine Market
1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (Above or equal to 65)
1.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2027
1.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2027
1.4.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 23-Valent Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Sites, Area Served, Product Type
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
3.5.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.6.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.7.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Analysis by Type
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2016-2021)
5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Analysis by Application
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 MSD
6.1.1 MSD Corporation Information
6.1.2 MSD Description and Business Overview
6.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.1.5 MSD Recent Developments/Updates
6.2 Sanofipasteur
6.2.1 Sanofipasteur Corporation Information
6.2.2 Sanofipasteur Description and Business Overview
6.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Sanofipasteur Recent Developments/Updates
6.3 CDIBP
6.3.1 CDIBP Corporation Information
6.3.2 CDIBP Description and Business Overview
6.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.3.5 CDIBP Recent Developments/Updates
7 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
7.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
7.4 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
8.3 23-Valent Pneumococcal Polysaccharide Vaccine Customers
9 23-Valent Pneumococcal Polysaccharide Vaccine Market Dynamics
9.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
9.2 23-Valent Pneumococcal Polysaccharide Vaccine Growth Drivers
9.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
9.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
10 Global Market Forecast
10.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2022-2027)
10.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2022-2027)
10.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of 23-Valent Pneumococcal Polysaccharide Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Growth Rate Comparison by Type (2021-2027)
Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Comparison by Application (2021-2027)
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Covered in This Study
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) of Key Manufacturers (2016-2021)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (US$/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 19. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 23. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 27. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 31. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 35. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2016-2021)
Table 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2016-2021)
Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2016-2021)
Table 43. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2016-2021)
Table 44. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2016-2021)
Table 47. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2016-2021)
Table 48. MSD Corporation Information
Table 49. MSD Description and Business Overview
Table 50. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 51. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 52. MSD Recent Developments/Updates
Table 53. Sanofipasteur Corporation Information
Table 54. Sanofipasteur Description and Business Overview
Table 55. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 56. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 57. Sanofipasteur Recent Developments/Updates
Table 58. CDIBP Corporation Information
Table 59. CDIBP Description and Business Overview
Table 60. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 61. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 62. CDIBP Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 66. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
Table 67. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Table 68. 23-Valent Pneumococcal Polysaccharide Vaccine Growth Drivers
Table 69. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 70. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Table 71. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2022-2027) & (K Dose)
Table 72. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 73. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 74. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2022-2027) & (K Dose)
Table 76. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 77. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 78. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 79. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2022-2027) & (K Dose)
Table 80. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 81. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 82. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type in 2020 & 2027
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-filled Syringe Product Picture
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application in 2020 & 2027
Figure 6. For Children (2-10)
Figure 7. For Person (10-64)
Figure 8. For The Old (Above or equal to 65)
Figure 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2027 (K Dose)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2020
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players: Market Share by Revenue in 2020
Figure 16. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2020
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2020
Figure 21. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2016-2021)
Figure 44. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2016-2021)
Figure 45. Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2020
Figure 46. Revenue Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2016-2021)
Figure 47. Revenue Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2020
Figure 48. Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 49. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 50. 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Industry Market Size
